Related Experiment Videos
Relationship between peritonitis and exit site infections in CAPD
G Eisele1, G R Bailie, B Lomaestro
1Division of Nephrology, Albany Medical College, NY.
Summary
Exit site infections in CAPD patients are infrequent without peritonitis. However, when peritonitis occurs first, exit site infections often follow, leading to high treatment failure rates with oral ciprofloxacin and intraperitoneal vancomycin.
Area of Science:
- Nephrology
- Infectious Diseases
- Clinical Medicine
Background:
- Peritonitis and exit site infections are common complications in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
- Understanding the relationship between these infections is crucial for effective management and patient outcomes.
Purpose of the Study:
- To retrospectively review the treatment of CAPD-related exit site infections using oral ciprofloxacin and intraperitoneal vancomycin.
- To determine the relationship between exit site infections and peritonitis in CAPD patients.
Main Methods:
- Retrospective review of 48 CAPD patients with 172 infection episodes.
- Analysis of treatment outcomes for exit site infections with oral ciprofloxacin and intraperitoneal vancomycin.
- Assessment of the temporal relationship between peritonitis and exit site infections.
Main Results:
- Exit site infections occurred infrequently without peritonitis (23% of occasions).
- 37% of patients with initial peritonitis subsequently developed exit site infections, with a mean onset of 8.2 months.
- 44% of exit site infections showed treatment failure, with 67% being relapses or possible relapses. *Staphylococcus aureus* was the most common isolate.
Conclusions:
- The combination of oral ciprofloxacin and intraperitoneal vancomycin was associated with a high incidence of treatment failures for CAPD-related exit site infections.
- Peritonitis may precede and contribute to the development of exit site infections, necessitating careful monitoring and management.
- Further research is needed to optimize treatment strategies and improve outcomes for these infections.